These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 24792576

  • 1. EGFR and HER2 exert distinct roles on colon cancer cell functional properties and expression of matrix macromolecules.
    Ellina MI, Bouris P, Aletras AJ, Theocharis AD, Kletsas D, Karamanos NK.
    Biochim Biophys Acta; 2014 Aug; 1840(8):2651-61. PubMed ID: 24792576
    [Abstract] [Full Text] [Related]

  • 2. Expression of matrix macromolecules and functional properties of EGF-responsive colon cancer cells are inhibited by panitumumab.
    Gialeli Ch, Theocharis AD, Kletsas D, Tzanakakis GN, Karamanos NK.
    Invest New Drugs; 2013 Jun; 31(3):516-24. PubMed ID: 22956286
    [Abstract] [Full Text] [Related]

  • 3. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
    Gan Y, Shi C, Inge L, Hibner M, Balducci J, Huang Y.
    Oncogene; 2010 Sep 02; 29(35):4947-58. PubMed ID: 20562913
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of EGF-induced migration and invasion by sulfated polysaccharide of Sepiella maindroni ink via the suppression of EGFR/Akt/p38 MAPK/MMP-2 signaling pathway in KB cells.
    Jiang W, Tian W, Ijaz M, Wang F.
    Biomed Pharmacother; 2017 Nov 02; 95():95-102. PubMed ID: 28830011
    [Abstract] [Full Text] [Related]

  • 6. Cardiotoxin III suppresses MDA-MB-231 cell metastasis through the inhibition of EGF/EGFR-mediated signaling pathway.
    Tsai PC, Hsieh CY, Chiu CC, Wang CK, Chang LS, Lin SR.
    Toxicon; 2012 Oct 02; 60(5):734-43. PubMed ID: 22683533
    [Abstract] [Full Text] [Related]

  • 7. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
    Chun J, Kim YS.
    Chem Biol Interact; 2013 Oct 05; 205(3):212-21. PubMed ID: 23867902
    [Abstract] [Full Text] [Related]

  • 8. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
    Fichter CD, Przypadlo CM, Buck A, Herbener N, Riedel B, Schäfer L, Nakagawa H, Walch A, Reinheckel T, Werner M, Lassmann S.
    J Pathol; 2017 Dec 05; 243(4):481-495. PubMed ID: 28940194
    [Abstract] [Full Text] [Related]

  • 9. Antitumor activity of taspine by modulating the EGFR signaling pathway of Erk1/2 and Akt in vitro and in vivo.
    Zhang Y, Zheng L, Zhang J, Dai B, Wang N, Chen Y, He L.
    Planta Med; 2011 Nov 05; 77(16):1774-81. PubMed ID: 21614750
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gallic acid abolishes the EGFR/Src/Akt/Erk-mediated expression of matrix metalloproteinase-9 in MCF-7 breast cancer cells.
    Chen YJ, Lin KN, Jhang LM, Huang CH, Lee YC, Chang LS.
    Chem Biol Interact; 2016 May 25; 252():131-40. PubMed ID: 27087131
    [Abstract] [Full Text] [Related]

  • 13. Curcumin attenuates hyperglycemia-driven EGF-induced invasive and migratory abilities of pancreatic cancer via suppression of the ERK and AKT pathways.
    Li W, Wang Z, Xiao X, Han L, Wu Z, Ma Q, Cao L.
    Oncol Rep; 2019 Jan 25; 41(1):650-658. PubMed ID: 30542713
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.
    Zuo JH, Zhu W, Li MY, Li XH, Yi H, Zeng GQ, Wan XX, He QY, Li JH, Qu JQ, Chen Y, Xiao ZQ.
    J Cell Biochem; 2011 Sep 25; 112(9):2508-17. PubMed ID: 21557297
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways.
    Kovacevic Z, Menezes SV, Sahni S, Kalinowski DS, Bae DH, Lane DJ, Richardson DR.
    J Biol Chem; 2016 Jan 15; 291(3):1029-52. PubMed ID: 26534963
    [Abstract] [Full Text] [Related]

  • 19. Docosahexaenoic Acid Downregulates EGF-Induced Urokinase Plasminogen Activator and Matrix Metalloproteinase 9 Expression by Inactivating EGFR/ErbB2 Signaling in SK-BR3 Breast Cancer Cells.
    Li CC, Yao HT, Cheng FJ, Hsieh YH, Lu CY, Wu CC, Liu KL, Chang JW.
    Nutr Cancer; 2015 Jan 15; 67(5):771-82. PubMed ID: 25970488
    [Abstract] [Full Text] [Related]

  • 20. Matrix metalloproteinase-7-catalyzed release of HB-EGF mediates deoxycholyltaurine-induced proliferation of a human colon cancer cell line.
    Cheng K, Xie G, Raufman JP.
    Biochem Pharmacol; 2007 Apr 01; 73(7):1001-12. PubMed ID: 17222808
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.